loader

eye disease

LATEST ARTICLES

Ocular Therapeutix™ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZA™

Nicox Receives Complete Response from FDA Related for AC-170

Ocular Therapeutix™ Begins Enrollment in First Phase 3 Clinical Trial with OTX-TP

Will GenSight's Product Candidate, GS010, Boost the Bottom Line?

Pharmaceutical Investing
pharmaceutical investing

Aerie Pharmaceuticals Sees Stock Soar

Ocular Therapeutix™ Announces Presentation at the Ophthalmology Innovation Summit (OIS) at the American Society of Retina Specialists (ASRS)

Biotech Investing

SeeThru Equity Initiates Coverage of Q BioMed Inc. Price Target $3.85

Novaliq Announces Last Patient Enrolled in Phase 2 Clinical Trial of CyclASol® for the Treatment of Moderate to Severe Dry Eye Disease

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES